Asparaginase (Kidrolase, Erwinase) shortage status
Discontinued
Source: Health Canada shortage reports · Updated Jul 9, 2026
Asparaginase products have been discontinued in Canada. See the reports below for which products and when.
A chemotherapy medication used to treat acute leukemia.
Products affected
0 / 2
Reports on file
10
Reports by product
The DIN is printed on your prescription label.
Discontinued
ERWINASE
10000UNIT · POWDER FOR SOLUTION · JAZZ PHARMACEUTICALS FRANCE SAS
DIN 02237815
Resolved
KIDROLASE
10000UNIT · POWDER FOR SOLUTION · JAZZ PHARMACEUTICALS FRANCE SAS
DIN 01926438 · ended Jul 7, 2021 · Requirements related to complying with good manufacturing practices.
Discontinued
KIDROLASE
10000UNIT · POWDER FOR SOLUTION · JAZZ PHARMACEUTICALS FRANCE SAS
DIN 01926438
Resolved
ERWINASE
10000UNIT · POWDER FOR SOLUTION · JAZZ PHARMACEUTICALS FRANCE SAS
DIN 02237815 · ended Mar 10, 2021 · Delays in the manufacture of the drug.
Resolved
ERWINASE
10000UNIT · POWDER FOR SOLUTION · JAZZ PHARMACEUTICALS FRANCE SAS
DIN 02237815 · ended Mar 10, 2021
Resolved
ERWINASE
10000UNIT · POWDER FOR SOLUTION · JAZZ PHARMACEUTICALS FRANCE SAS
DIN 02237815 · ended Mar 10, 2021 · Disruption of the manufacture of the drug.
Resolved
ERWINASE
10000UNIT · POWDER FOR SOLUTION · JAZZ PHARMACEUTICALS FRANCE SAS
DIN 02237815 · ended Mar 10, 2021 · Delay in shipping of the drug.
Resolved
ERWINASE
10000UNIT · POWDER FOR SOLUTION · JAZZ PHARMACEUTICALS FRANCE SAS
DIN 02237815 · ended Aug 10, 2018 · Unanticipated delay in the scheduled release of the next batch of product
Resolved
ERWINASE
10000UNIT · POWDER FOR SOLUTION · JAZZ PHARMACEUTICALS FRANCE SAS
DIN 02237815 · ended May 25, 2018 · Unexpected delays in release of the next batch of the product
Resolved
ERWINASE
10000UNIT · POWDER FOR SOLUTION · JAZZ PHARMACEUTICALS FRANCE SAS
DIN 02237815 · ended Jun 30, 2017
What's happening
One or more Asparaginase products have been permanently discontinued by their manufacturers. If your product is affected, ask your pharmacist about equivalent products still on the market.
Asparaginase is classified under “OTHER ANTINEOPLASTIC AGENTS” (ATC L01XX).
Recent changes
No changes recorded yet.
Common questions
What is Asparaginase used for?
A chemotherapy medication used to treat acute leukemia.
When will Asparaginase be back in stock in Canada?
Manufacturers have not provided a reliable end date. This page updates automatically as soon as an estimate is filed.
Why is Asparaginase in shortage?
See the reports above; manufacturers must state a reason (most commonly manufacturing disruption or a surge in demand) when filing with Health Canada.
What can my pharmacist do about it?
Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.
Email alerts
Get an email when this drug's status changes. Double opt-in, one-click unsubscribe.
Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.